David Gyorke

Cholestech Corp. provides diagnostic tools and information for risk assessment and therapeutic monitoring of heart disease, inflammatory disorders, and diabetes. It manufactures LDX System, multi-analytic testing system, and accessories to perform individual tests. The company was founded in 1988 and is headquartered in Hayward, CA.

Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY.

NeoVista, Inc. develops device-based therapy for age-related macular degeneration (AMD). The firm's technology utilizes targeted strontium 90 beta radiation in a one-time surgical procedure and this technology has the possibility to reduce the burden that wet AMD places on healthcare providers, patients, and the healthcare system. The company was founded in 2002 and is headquartered in Newark, CA.

Nanomix, Inc. provides nano technology solutions. It is a nanotechnology company focused on development of next generation Point of Care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings. The firm's nanoscale electronic sensors have enabled the development of the next generation of Point of Care testing systems that can be used in any setting. The company's mobile diagnostic platform performs multiple in-vitro diagnostic assays simultaneously from a single whole-blood sample. Nanomix was founded by Alexander Zettl and Marvin L. Cohen in September 2000 and is headquartered in Emeryville, CA.

Farallon Medical, Inc. provided coagulation-monitoring meters to measure prothrombin time. It also provided test strips for monitoring anticoagulation therapy. The company was founded in 2002 and was headquartered in Hayward, CA.

Chembio Diagnostic Systems, Inc. engages in the development, manufacture, and commercialization of point-of-care diagnostic tests and technology for the detection of infectious diseases. It offers human and veterinary diagnostic products. The company was founded in 1985 and is headquartered in Medford, NY.

Radiance Therapeutics, Inc. engages in ophthalmic therapeutic innovation, is commercializing a clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery. It specializes in novel anti-metabolite therapy for glaucoma drainage surgery. The company is headquartered in Tucson, AZ.